HIMS — Hims & Hers Health, Inc.
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 1773751 ·
Last close
$29.97
Market Cap
$6.74B
52W High
$39.05
52W Low
$21.53
ADV30
14,820,188
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 608,104,000 | 396,787,000 | -78,323,000 | -92,115,000 | 2,267,043,000 | 222,266,000 | 1,820,876,000 |
| Dec 2025 | 617,818,000 | 444,435,000 | 9,186,000 | 20,601,000 | 2,154,705,000 | 228,616,000 | 1,613,777,000 |
| Sep 2025 | 598,976,000 | 442,058,000 | 11,807,000 | 15,774,000 | 2,233,304,000 | 345,778,000 | 1,652,322,000 |
| Jun 2025 | 544,833,000 | 416,196,000 | 26,723,000 | 42,505,000 | 1,877,582,000 | 1,124,582,000 | 1,314,886,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$280,272,000
Investing CF
$-1,007,608,000
Financing CF
$674,758,000
CapEx
$-219,877,000
Dividends Paid
—
Buybacks
$-89,960,000
EPS Diluted TTM
$-0.09
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-205,887,000
Inventory
$79,073,000
Receivables
$149,620,000
ST Investments
$528,609,000
EBIT TTM
$-30,607,000
Pretax Income TTM
$-38,122,000
Interest Exp TTM
—
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,578,112,000
EBITDA
$-10,177,000
Free Cash Flow
$849,437,248
Enterprise Value
$7,697,593,856
Total Cash
$841,048,000
Total Debt
$1,546,238,976
Shares Out
224,935,790
Trailing EPS
$-0.63
Book Value
$1.39
ROE
-32.0%
ROA
-2.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,347,637,000 | 105,613,000 | 128,365,000 | 2,154,705,000 | 1,613,777,000 | — | 300,006,000 |
| Dec 2024 | 1,476,514,000 | 61,903,000 | 126,038,000 | 707,539,000 | 230,823,000 | — | 251,084,000 |
| Dec 2023 | 872,000,000 | -29,453,000 | -23,546,000 | 441,186,000 | 97,157,000 | — | 73,483,000 |
| Dec 2022 | 526,916,000 | -68,697,000 | -65,678,000 | 366,341,000 | 54,600,000 | — | -26,531,000 |
TTM Snapshot
Revenues TTM
$847,264,000
NetIncome TTM
$33,240,000
OpCashFlow TTM
$0
Assets (Latest)
$707,539,000
Forward EPS
$1.26
Max Pain — expiry 2026-08-21
max pain strike: $29.00 · spot: $28.77 · call oi: 103,800 · put oi: 63,518
Expected Move to 2026-08-21:
±$2.41
(8.38%) —
implied range
$26.36 –
$31.18
· ATM straddle on $29.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CHE | CHEMED CORP | $7.07B | $541.02 | — |
| PACS | PACS Group, Inc. | $7.20B | $45.47 | — |
| CAI | Caris Life Sciences, Inc. | $6.29B | $22.26 | — |
| RDNT | RadNet, Inc. | $6.06B | $76.95 | — |
| SHC | Sotera Health Co | $5.39B | $18.89 | — |
News headlines (Yahoo Finance, 1h cache)
Hims & Hers Health (HIMS) Stock Looks Cheap Even With Legal Risk
2026-08-12 09:09 · Yahoo
Is Hims The Next Big Name In Peptides? Shares Topple Despite Sales Beat.
2026-08-11 20:03 · Yahoo
Will Hims & Hers’ Higher 2026 Revenue Guidance Amid Rising Losses Change HIMS’s Investment Narrative?
2026-08-11 16:15 · Yahoo
Hims & Hers stock trims losses following quarterly results
2026-08-11 15:50 · Yahoo
Hims & Hers Q2 revenue beat offset by wider-than-expected loss
2026-08-11 15:35 · Yahoo
Citi Says Hims & Hers’ Full-Year Outlook Indicates ‘Hefty’ Q4 Earnings Lift, Warns Of Execution Risks
2026-08-11 15:26 · Yahoo
Hims & Hers Health Sees Mixed Q2 as Gross Margin, FCF Weigh, Morgan Stanley Says
2026-08-11 15:07 · Yahoo
Hims & Hers' Revenue Growth Comes at a Cost
2026-08-11 12:49 · Yahoo
Hims & Hers Raises Outlook as Cash Flow Weakens
2026-08-11 12:33 · Yahoo
Hims & Hers Q2 2026 earnings: loss despite revenue beat
2026-08-11 11:23 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.